Reply to "Comment on 'In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma'".

导出原文传递

翻译打印收藏纠错

第一作者： Ilse R,Dubbelboer

第一单位： Department of Pharmacy, Uppsala University , Box 580, 751 23 Uppsala, Sweden.

作者： Ilse R,Dubbelboer ^[1] ; Elsa,Lilienberg ^[1] ; Amar,Karalli ^[2] ; Rimma,Axelsson ^[2] ; Torkel B,Brismar ^[2] ; Charlotte,Ebeling Barbier ^[3] ; Agneta,Norén ^[4] ; Frans,Duraj ^[4] ; Mikael,Hedeland ^[5] ; Ulf,Bondesson ^[5] ; Erik,Sjögren ^[1] ; Per,Stål ^[6] ; Rickard,Nyman ^[3] ; Hans,Lennernäs ^[1]

作者单位： Department of Pharmacy, Uppsala University , Box 580, 751 23 Uppsala, Sweden. ^[1] Department of Radiology, Karolinska University Hospital in Huddinge , Stockholm, Sweden.;Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet , Stockholm, Sweden. ^[2] Department of Radiology, Uppsala University Hospital, Uppsala University , 751 85 Uppsala, Sweden. ^[3] Department of Surgical Sciences, Uppsala University Hospital, Uppsala University , 751 85 Uppsala, Sweden. ^[4] Department of Chemistry, Environment and Feed Hygiene, National Veterinary Institute (SVA) , 751 89 Uppsala, Sweden. ^[5] Unit of Gastroenterology, Department of Internal Medicine Huddinge, Karolinska Institutet , Stockholm, Sweden.;Department of Digestive Diseases, Karolinska University Hospital in Huddinge , Stockholm, Sweden. ^[6]

关键词 Lipiodol doxorubicin drug-eluting beads hepatocelluar carcinoma image-guided transarterial tumor therapy interventional radiology liver cancer local therapy transarterial chemoembolization (TACE)